What does this research mean for the field?

The 3% annual reduction in long-term post-myocardial infarction mortality in elderly patients is primarily explained by the increased use of discharge cardiovascular medications. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To evaluate the relationship between increasing post-discharge use of cardiovascular medications and long-term mortality trends in elderly survivors of myocardial infarction.

September 19, 2026Journal of the American College of CardiologyOpen Access

Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge

Q: What is the clinical evidence from this study?

Study design: Cohort. Population: Myocardial infarction (n=21484). Intervention: Increased use of cardiovascular medications (statins, beta-blockers, ACEIs/ARBs, antiplatelets) vs. Unadjusted time trend. Primary outcome: Long-term mortality (annual trend) (HR 0.97, 95% CI 0.97-0.98).

View Full Paper

Ask AI

Bookmark

Key result

Increased CV medication use completely explains the ~3% annual reduction in long-term post-MI mortality.

Key Points

To evaluate the relationship between increasing post-discharge use of cardiovascular medications and long-term mortality trends in elderly survivors of myocardial infarction.
Analyzed linked Medicare and pharmacy assistance program records (1995–2004) from two states for N=21,484 elderly patients who survived ≥30 days post-discharge after myocardial infarction.
Identified filled prescriptions within 30 days of discharge for statins, beta-blockers, ACE inhibitors/ARBs, and antiplatelet agents.
Evaluated long-term mortality across 74,982 person-years using multivariable Cox proportional hazards regression models adjusted for demographics, comorbidities, and in-hospital coronary interventions.
Adjusted mortality after myocardial infarction decreased significantly from 1995 to 2004, with an annual hazard ratio of 0.97 (95% CI, 0.97 to 0.98), representing a 3% relative risk reduction per year.
Adjustment for post-discharge use of statins, beta-blockers, ACE inhibitors/ARBs, and antiplatelet agents completely eliminated the temporal survival trend (hazard ratio, 1.00; 95% CI, 0.99 to 1.01).

Study Design

Type

Cohort (n=21,484)

Multicenter

Yes

PICO

Population

21,484 elderly patients who survived ≥30 days after discharge for myocardial infarction, tracked for 74,982 person-years to assess mortality trends.

Exposure / Comparator

Increased use of cardiovascular medications (statins, beta-blockers, ACEIs/ARBs, antiplatelets) vs Unadjusted time trend

Primary Outcome

Long-term mortality (annual trend) — HR 0.97 (0.97-0.98)

Main Result

Hazard Ratio: 0.97 (95% CI 0.97–0.98)

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Cohort study reveals declining mortality after myocardial infarction in elderly patients, indicating improved survival is driven by post-discharge cardiovascular drug use.

Cite This Study

Setoguchi et al. (2008) conducted a cohort in Myocardial infarction (n=21,484). Increased use of cardiovascular medications (statins, beta-blockers, ACEIs/ARBs, antiplatelets) vs. Unadjusted time trend was evaluated on Long-term mortality (annual trend) (HR 0.97, 95% CI 0.97-0.98). The 3% annual reduction in long-term mortality after myocardial infarction from 1995 to 2004 (HR 0.97; 95% CI 0.97-0.98) was completely explained by increased use of cardiovascular medications.

synapsesocial.com/papers/6aadfe74caa0b306db0bb291 https://doi.org/10.1016/j.jacc.2007.10.063

View Full Paper

Ask AI

Bookmark

Implication

Cohort study reveals declining mortality after myocardial infarction in elderly patients, indicating improved survival is driven by post-discharge cardiovascular drug use.

Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge

Key Points

Study Design

PICO

Main Result

Discussion

Implication

Cite This Study

Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge

Key Points

Study Design

PICO

Main Result

Discussion

Implication

Cite This Study

Also Consider

Also Consider